YS BIOPHARMA CO LTD (YS)
KYG9845F1090 - Common Stock
YS BIOPHARMA CO LTD
NASDAQ:YS (4/25/2024, 7:26:48 PM)
Premarket: 0.795 0 (0%)0.795
-0.02 (-1.85%)
Company Profile
YS Biopharma Co. Ltd. operates as a biopharmaceutical company, which is dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The company is headquartered in Beijing, Beijing and currently employs 773 full-time employees. The company went IPO on 2021-07-30. The firm's vaccine product YSJATM rabies vaccine has been commercialized. The firm also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.
Company Info
YS BIOPHARMA CO LTD
Building No. 2, 38 Yongda Road, Daxing Biomedical Industry Park
Beijing BEIJING
P: 17327133678
Employees: 773
Website: https://www.ysbiopharm.com/
YS News
7 days ago - InvestorPlaceYS Stock Earnings: YS Biopharma Co Misses EPS, Beats Revenue for Q3 2024YS stock results show that YS Biopharma Co missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024.
7 days ago - BusinessInsiderYS Stock Earnings: YS Biopharma Co Misses EPS, Beats Revenue for Q3 2024InvestorPlace - Stock Market News, Stock Advice & Trading Tips YS Biopharma Co (NASDAQ:YS) just reported results for the third quarter of 2024...
7 days ago - YS Biopharma Co., Ltd.YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...
8 days ago - YS Biopharma Co., Ltd.YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine/PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...
10 days ago - YS Biopharma Co., Ltd.YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...
2 months ago - YS Biopharma Co., Ltd.YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries/PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...
YS Twits
Here you can normally see the latest stock twits on YS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
